A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A

NCT01724814 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

DRUG: HM12460A
DRUG: Placebo

Sponsor

Hanmi Pharmaceutical Company Limited